Skip to main content

Intuitive Surgical Value Stock - Dividend - Research Selection

Intuitive surgical

ISIN: US46120E6023 , WKN: 888024

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Intuitive designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories, which taken together, are advanced surgical systems that we consider an advanced generation of surgery. This advanced generation of surgery, which we call da Vinci surgery, combines the benefits of minimally invasive surgery (“MIS”) for patients with the ease of use, precision and dexterity of open surgery. A da Vinci Surgical System consists of a surgeon’s console, a patient-side cart, and a high performance vision system. The da Vinci Surgical System translates a surgeon’s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions, or ports. The da Vinci Surgical System is designed to provide its operating surgeons with intuitive control, range of motion, fine tissue manipulation capability and Three Dimensional (“3-D”), High-Definition (“HD”) vision while simultaneously allowing surgeons to work through the small ports enabled by MIS procedures.

 

da Vinci Surgery utilizes computational, robotic and imaging technologies to enable improved patient outcomes compared to other surgical and non-surgical therapies. da Vinci Surgery is aimed towards advancing the critical surgical ideals of entering the body less invasively, seeing anatomy more clearly, interacting with tissue more precisely and building surgical skills. The da Vinci Surgical System enables surgeons to avail or improve the benefits of MIS to many patients who would otherwise undergo a more invasive surgery. Surgeons using the da Vinci system operate while seated comfortably at a console viewing a 3-D, HD image of the surgical field. This immersive visualization connects surgeons to the surgical field and their instruments. While seated at the console, the surgeon manipulates instrument controls in a natural manner, similar to the more intuitive open surgery technique. Our technology is designed to provide surgeons with a range of motion in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon’s hand. In designing our products, we focus on making our technology easy to use.

 

Source: www.sec.gov

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


UBS reveals what’s next for Intuitive Surgical stock

2026-07-30
Intuitive Surgical (ISRG), maker of the da Vinci surgical robot, has been one of the year's most punished large-cap healthcare names, down about 37% even as revenue keeps climbing. Analysts spent months cutting targets. Then one firm broke from the pack and told investors the fear had gone too far. ...

Is ISRG Winning the Next Phase of Robotic Surgery Beyond Urology?

2026-07-30
ISRG is expanding robotic surgery beyond urology as general surgery and newer specialties gain traction, creating fresh avenues for long-term procedure growth.

ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise

2026-07-30
Align Technology shares rise after Q2 earnings and revenues beat estimates, fueled by record Clear Aligner shipments and wider non-GAAP margins.

Intuitive Surgical (ISRG) Could Be 43% Undervalued On Bylaw Changes And Share Price Weakness

2026-07-29
Intuitive Surgical (ISRG) has just overhauled its bylaws, reshaping how shareholders can nominate directors, submit proposals, and call special meetings. These governance changes arrive while the stock is still trading well below its recent highs. See our latest analysis for Intuitive Surgical. Over the last year, Intuitive Surgical’s share price return has been pressured, with the year to date share price return down 35.62% and the 90 day share price return down 20.28%, even though the 3...

This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run

2026-07-29
Medtronic could finally be on the cusp of a long-awaited turnaround.

The Best House On The Block Costs The Most: ISRG

2026-07-29
In the world of robotic surgery, one company is both the undisputed leader and the most expensive name on the shelf, forcing investors to ask if operational brilliance is worth the high price of admission.

ISRG Q2 Earnings Call Signals Durable Demand & U.S. Caution

2026-07-28
ISRG pairs durable platform demand and higher margin guidance with caution on softer U.S. procedure growth and deferred care.

Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685

2026-07-28
Intuitive Surgical (NASDAQ:ISRG) trades at $356.83, while the average Wall Street price target sits at $484.40. That leaves roughly a 36% gap between current price and Street consensus. Intuitive builds the da Vinci robotic surgery platform and the Ion lung biopsy system, dominating soft tissue surgical robotics. Wall Street has debated whether that moat holds ... Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls

2026-07-28
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls

UBS starts medtech coverage, favors Intuitive Surgical and Enovis

2026-07-28
Investing.com -- UBS initiated coverage on four U.S. medical technology companies on Monday, taking a bullish stance on robotic surgery specialist Intuitive Surgical and orthopedic products maker Enovis, while adopting a more cautious outlook on sleep apnea device manufacturer Inspire Medical Systems and a neutral view on Integra LifeSciences.